Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia

NCT00380575 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyponatremia

Interventions

DRUG: YM087

Sponsor

Cumberland Pharmaceuticals

Collaborators

[object Object]